Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size, Status and Forecast 2020-2026

May 2020 | 93 pages | ID: GF9AD8B0F09CEN
QYResearch

Abstracts

This report focuses on the global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Qiagen NV
• GE Healthcare
• Agilent Technologies
• F Hoffman La Roche
• Foundation Medicine
• Thermo Fisher Scientific Inc.
• Leica Biosystems Nussloch GmBH
• Pfizer

Market segment by Type, the product can be split into

• PCR
• In-situ Hybridization
• Immunohistochemistry
• Sequencing
• Others

Market segment by Application, split into

• Oncology
• Neurological Disorders
• Cardiovascular Disease
• Immunological Disorders
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) status, future forecast, growth opportunity, key market and key players.
• To present the Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue
1.4 Market Analysis by Type
  1.4.1 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 PCR
  1.4.3 In-situ Hybridization
  1.4.4 Immunohistochemistry
  1.4.5 Sequencing
  1.4.6 Others
1.5 Market by Application
  1.5.1 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application: 2020 VS 2026
  1.5.2 Oncology
  1.5.3 Neurological Disorders
  1.5.4 Cardiovascular Disease
  1.5.5 Immunological Disorders
  1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Perspective (2015-2026)
2.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Growth Trends by Regions
  2.2.1 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Historic Market Share by Regions (2015-2020)
  2.2.3 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Growth Strategy
  2.3.6 Primary Interviews with Key Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Players by Market Size
  3.1.1 Global Top Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Players by Revenue (2015-2020)
  3.1.2 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Market Share by Players (2015-2020)
  3.1.3 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Concentration Ratio
  3.2.1 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue in 2019
3.3 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Key Players Head office and Area Served
3.4 Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Product Solution and Service
3.5 Date of Enter into Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Historic Market Size by Type (2015-2020)
4.2 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Forecasted Market Size by Type (2021-2026)

5 PHARMACOGENOMICS TECHNOLOGY/THERANOSTICS/COMPANION DIAGNOSTICS (CDX) BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2015-2020)
5.2 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2015-2020)
6.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Key Players in North America (2019-2020)
6.3 North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2015-2020)
6.4 North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2015-2020)
7.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Key Players in Europe (2019-2020)
7.3 Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2015-2020)
7.4 Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2015-2020)

8 CHINA

8.1 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2015-2020)
8.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Key Players in China (2019-2020)
8.3 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2015-2020)
8.4 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2015-2020)
9.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Key Players in Japan (2019-2020)
9.3 Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2015-2020)
9.4 Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2015-2020)
10.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2015-2020)
10.4 Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2015-2020)

11 INDIA

11.1 India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2015-2020)
11.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Key Players in India (2019-2020)
11.3 India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2015-2020)
11.4 India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2015-2020)
12.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Key Players in Central & South America (2019-2020)
12.3 Central & South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2015-2020)
12.4 Central & South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Qiagen NV
  13.1.1 Qiagen NV Company Details
  13.1.2 Qiagen NV Business Overview and Its Total Revenue
  13.1.3 Qiagen NV Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
  13.1.4 Qiagen NV Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020))
  13.1.5 Qiagen NV Recent Development
13.2 GE Healthcare
  13.2.1 GE Healthcare Company Details
  13.2.2 GE Healthcare Business Overview and Its Total Revenue
  13.2.3 GE Healthcare Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
  13.2.4 GE Healthcare Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020)
  13.2.5 GE Healthcare Recent Development
13.3 Agilent Technologies
  13.3.1 Agilent Technologies Company Details
  13.3.2 Agilent Technologies Business Overview and Its Total Revenue
  13.3.3 Agilent Technologies Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
  13.3.4 Agilent Technologies Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020)
  13.3.5 Agilent Technologies Recent Development
13.4 F Hoffman La Roche
  13.4.1 F Hoffman La Roche Company Details
  13.4.2 F Hoffman La Roche Business Overview and Its Total Revenue
  13.4.3 F Hoffman La Roche Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
  13.4.4 F Hoffman La Roche Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020)
  13.4.5 F Hoffman La Roche Recent Development
13.5 Foundation Medicine
  13.5.1 Foundation Medicine Company Details
  13.5.2 Foundation Medicine Business Overview and Its Total Revenue
  13.5.3 Foundation Medicine Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
  13.5.4 Foundation Medicine Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020)
  13.5.5 Foundation Medicine Recent Development
13.6 Thermo Fisher Scientific Inc.
  13.6.1 Thermo Fisher Scientific Inc. Company Details
  13.6.2 Thermo Fisher Scientific Inc. Business Overview and Its Total Revenue
  13.6.3 Thermo Fisher Scientific Inc. Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
  13.6.4 Thermo Fisher Scientific Inc. Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020)
  13.6.5 Thermo Fisher Scientific Inc. Recent Development
13.7 Leica Biosystems Nussloch GmBH
  13.7.1 Leica Biosystems Nussloch GmBH Company Details
  13.7.2 Leica Biosystems Nussloch GmBH Business Overview and Its Total Revenue
  13.7.3 Leica Biosystems Nussloch GmBH Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
  13.7.4 Leica Biosystems Nussloch GmBH Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020)
  13.7.5 Leica Biosystems Nussloch GmBH Recent Development
13.8 Pfizer
  13.8.1 Pfizer Company Details
  13.8.2 Pfizer Business Overview and Its Total Revenue
  13.8.3 Pfizer Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
  13.8.4 Pfizer Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020)
  13.8.5 Pfizer Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Key Market Segments
Table 2. Key Players Covered: Ranking by Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue
Table 3. Ranking of Global Top Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of PCR
Table 6. Key Players of In-situ Hybridization
Table 7. Key Players of Immunohistochemistry
Table 8. Key Players of Sequencing
Table 9. Key Players of Others
Table 10. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Regions (2015-2020)
Table 14. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Growth Strategy
Table 20. Main Points Interviewed from Key Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Players
Table 21. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue by Players (2015-2020) (Million US$)
Table 22. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Players (2015-2020)
Table 23. Global Top Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) as of 2019)
Table 24. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Product Solution and Service
Table 27. Date of Enter into Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2015-2020) (Million US$)
Table 30. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Type (2015-2020)
Table 31. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Market Share by Type (2021-2026)
Table 32. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Application (2015-2020)
Table 33. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2015-2020) (Million US$)
Table 34. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Application (2021-2026)
Table 35. North America Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share (2019-2020)
Table 37. North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2015-2020) (Million US$)
Table 38. North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Type (2015-2020)
Table 39. North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2015-2020) (Million US$)
Table 40. North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application (2015-2020)
Table 41. Europe Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share (2019-2020)
Table 43. Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Type (2015-2020)
Table 45. Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application (2015-2020)
Table 47. China Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (2019-2020) (Million US$)
Table 48. China Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share (2019-2020)
Table 49. China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2015-2020) (Million US$)
Table 50. China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Type (2015-2020)
Table 51. China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2015-2020) (Million US$)
Table 52. China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application (2015-2020)
Table 53. Japan Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share (2019-2020)
Table 55. Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Type (2015-2020)
Table 57. Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share (2019-2020)
Table 61. Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Type (2015-2020)
Table 63. Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application (2015-2020)
Table 65. India Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (2019-2020) (Million US$)
Table 66. India Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share (2019-2020)
Table 67. India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2015-2020) (Million US$)
Table 68. India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Type (2015-2020)
Table 69. India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2015-2020) (Million US$)
Table 70. India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share (2019-2020)
Table 73. Central & South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Type (2015-2020)
Table 75. Central & South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application (2015-2020)
Table 77. Qiagen NV Company Details
Table 78. Qiagen NV Business Overview
Table 79. Qiagen NV Product
Table 80. Qiagen NV Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020) (Million US$)
Table 81. Qiagen NV Recent Development
Table 82. GE Healthcare Company Details
Table 83. GE Healthcare Business Overview
Table 84. GE Healthcare Product
Table 85. GE Healthcare Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020) (Million US$)
Table 86. GE Healthcare Recent Development
Table 87. Agilent Technologies Company Details
Table 88. Agilent Technologies Business Overview
Table 89. Agilent Technologies Product
Table 90. Agilent Technologies Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020) (Million US$)
Table 91. Agilent Technologies Recent Development
Table 92. F Hoffman La Roche Company Details
Table 93. F Hoffman La Roche Business Overview
Table 94. F Hoffman La Roche Product
Table 95. F Hoffman La Roche Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020) (Million US$)
Table 96. F Hoffman La Roche Recent Development
Table 97. Foundation Medicine Company Details
Table 98. Foundation Medicine Business Overview
Table 99. Foundation Medicine Product
Table 100. Foundation Medicine Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020) (Million US$)
Table 101. Foundation Medicine Recent Development
Table 102. Thermo Fisher Scientific Inc. Company Details
Table 103. Thermo Fisher Scientific Inc. Business Overview
Table 104. Thermo Fisher Scientific Inc. Product
Table 105. Thermo Fisher Scientific Inc. Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020) (Million US$)
Table 106. Thermo Fisher Scientific Inc. Recent Development
Table 107. Leica Biosystems Nussloch GmBH Company Details
Table 108. Leica Biosystems Nussloch GmBH Business Overview
Table 109. Leica Biosystems Nussloch GmBH Product
Table 110. Leica Biosystems Nussloch GmBH Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020) (Million US$)
Table 111. Leica Biosystems Nussloch GmBH Recent Development
Table 112. Pfizer Business Overview
Table 113. Pfizer Product
Table 114. Pfizer Company Details
Table 115. Pfizer Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020) (Million US$)
Table 116. Pfizer Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Type: 2020 VS 2026
Figure 2. PCR Features
Figure 3. In-situ Hybridization Features
Figure 4. Immunohistochemistry Features
Figure 5. Sequencing Features
Figure 6. Others Features
Figure 7. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application: 2020 VS 2026
Figure 8. Oncology Case Studies
Figure 9. Neurological Disorders Case Studies
Figure 10. Cardiovascular Disease Case Studies
Figure 11. Immunological Disorders Case Studies
Figure 12. Others Case Studies
Figure 13. Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Report Years Considered
Figure 14. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Regions: 2020 VS 2026
Figure 16. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Players in 2019
Figure 19. Global Top Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue in 2019
Figure 21. North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Qiagen NV Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Qiagen NV Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020)
Figure 30. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. GE Healthcare Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020)
Figure 32. Agilent Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Agilent Technologies Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020)
Figure 34. F Hoffman La Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. F Hoffman La Roche Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020)
Figure 36. Foundation Medicine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Foundation Medicine Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020)
Figure 38. Thermo Fisher Scientific Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Thermo Fisher Scientific Inc. Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020)
Figure 40. Leica Biosystems Nussloch GmBH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Leica Biosystems Nussloch GmBH Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020)
Figure 42. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Pfizer Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020)
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed